Literature DB >> 8612329

Coloboma hyperactive mutant exhibits delayed neurobehavioral developmental milestones.

C J Heyser1, M C Wilson, L H Gold.   

Abstract

The coloboma mutation (Cm) is a neutron-irradiation induced gene deletion located on the distal portion of mouse chromosome 2. This deletion region includes a gene encoding the synaptic vesicle docking fusion protein, synaptosomal-associated protein of 25 kDa (SNAP-25). The resulting mutation is semi-dominant with heterozygote mice exhibiting a triad of phenotypic abnormalities that comprise profound spontaneous hyperactivity, head bobbing and a prominent eye dysmorphology. Because the expression pattern of two SNAP-25 isoforms begins to change during the first postnatal week, neurobehavioral developmental milestones were examined in order to determine if the expression of the coloboma behavioral phenotype could be detected during this period of postnatal development. The early classification of coloboma mutant offspring may help to further describe the penetrance of this mutation as well as the contribution of developmental changes to the adult behavioral phenotype. The coloboma mutation resulted in delays in some tests of complex motor skills including righting reflex and bar holding. In addition, coloboma mutants were characterized by body weight differences (first appearance day 7) and hyperreactivity to touch (day 11) and head bobbing (day 14). These data demonstrate disruptions in the time course of attaining developmental milestones in coloboma mutants and provide further evidence supporting the hypotheses that alterations in Snap gene expression are associated with functional behavioral consequences in developing offspring.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8612329     DOI: 10.1016/0165-3806(95)00130-6

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  14 in total

1.  Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain.

Authors:  Alfredo Ramos-Miguel; Kristina Gicas; Jehan Alamri; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Fang Cai; Weihong Song; Alasdair M Barr; William G Honer
Journal:  Neuroscience       Date:  2018-12-21       Impact factor: 3.590

Review 2.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

Review 3.  SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond.

Authors:  Renata Basso Cupertino; Djenifer B Kappel; Cibele Edom Bandeira; Jaqueline Bohrer Schuch; Bruna Santos da Silva; Diana Müller; Claiton Henrique Dotto Bau; Nina Roth Mota
Journal:  J Neural Transm (Vienna)       Date:  2016-02-08       Impact factor: 3.575

Review 4.  Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

Authors:  Holly R Robertson; Guoping Feng
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

5.  D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.

Authors:  Xueliang Fan; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2006-12-29       Impact factor: 5.996

6.  Role of SNAP25 explored in eastern Indian attention deficit hyperactivity disorder probands.

Authors:  Kanyakumarika Sarkar; Nipa Bhaduri; Paramita Ghosh; Swagata Sinha; Anirban Ray; Anindita Chatterjee; Kanchan Mukhopadhyay
Journal:  Neurochem Res       Date:  2011-10-14       Impact factor: 3.996

Review 7.  Review of rodent models of attention deficit hyperactivity disorder.

Authors:  Samantha L Regan; Michael T Williams; Charles V Vorhees
Journal:  Neurosci Biobehav Rev       Date:  2021-11-27       Impact factor: 8.989

8.  Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.

Authors:  Ilja Spellmann; Norbert Müller; Richard Musil; Peter Zill; Anette Douhet; Sandra Dehning; Anja Cerovecki; Brigitta Bondy; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03-17       Impact factor: 5.270

9.  A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.

Authors:  Vilte E Barakauskas; Clare L Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen E Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William G Honer
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

10.  SNAP-25 in neuropsychiatric disorders.

Authors:  Irene Corradini; Claudia Verderio; Mariaelvina Sala; Michael C Wilson; Michela Matteoli
Journal:  Ann N Y Acad Sci       Date:  2009-01       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.